FDA Cites Adulteration In Warning Letter To Juice Beauty Manufacturer

FDA’s latest warning letter to a cosmetics firm departs from the agency’s crackdown on drug-like structure/function claims, targeting contract manufacturer Gemdo Cosmetics for facility conditions and evidence of microbial contamination that cause its products to be adulterated under the Federal Food, Drug and Cosmetic Act. In the April 16 letter, FDA cites eye products produced at the firm’s plant, including Juice Beauty offerings subject to a July 2014 recall.